- 5817
- 402
- 0
- 0
- 7
- Help Ukraine
About the solution
The patent pending system I have developed is designed to relieve the chronic symptoms of dry mouth commonly known as xerostomia.
Individuals suffering from Sjögren's disease, scleroderma, diabetes, and the effects of chemo/radiation therapy as well as polypharmacy suffer with chronic dry mouth and mucositis. These patients are at a high risk of dental caries formation, opportunistic infections, poor speech, poor nutrition, attrition of the teeth and supporting structures, as well as numerous other complications impacting their quality of life.
This system is designed to alleviate the discomfort brought on by the diminution or absence of salivary production through a novel approach. It predictably and consistently offers relief from dry mouth both during waking AND sleeping hours.
It is the hope of the inventor and developer that its introduction will stimulate research into not only subjective relief of symptoms, but also its application in the realm of hydration therapy and medicinal delivery.
Beta field testing by volunteers has resulted in phenomenally positive feedback as well as improvements in function and design through recommendations. The current pool of testers, though small, has been of individuals severely affected by this condition. All participants have noted an improvement in their quality of life.
Currently in the final stages of development, it is hoped that in the coming new year it will be made available to the public through the fitting and guidance of licensed health care providers. Please inform individuals suffering from these debilitating symptoms to monitor this site for updates as they become available.
这些解决方案不应包括使用药物,化学品或生物制品(包括食品);创伤性设备;冒犯性的,商业或内在危险的内容。该解决方案未经医学验证。请谨慎进行!如果您有任何疑问,请咨询健康专家。
-
• Sat, 12/17/2016 - 14:06
In response to a friend's question, let me clarify that this device/system is NOT a cure for chronic dry mouth, it is intended to rehydrate the oral cavity and restore its buffering capacity.
The mouth is its own unique ecosystem and "bad" acid producing bacteria make it more acidic without saliva. It is designed to dilute and neutralize these acids to help resist tooth demineralization that leads to tooth decay.
Embodiments in its design will also allow it to be used for localized and diffuse medicine delivery once PROPER clinical trials are performed.
Thank you,
Dr. Cash
This work is being financed by the FCT project with the reference PTDC/EGE-OGE/7995/2020
Copyright © 2024 Patient Innovation.
Powered by Orange Bird
Not a member yet? Register now, it's free!
Dr. Cash • Fri, 12/16/2016 - 13:37
Electronics developer is putting the circuit layout down as I type.... Looking to have "official" professionally made beta testing units by the new year!! Then it is the FDA hurdle to surmount! Wish me luck and send prayers. I pray every day to bring COMFORT to those suffering.
God Bless....
Dr. Cash